Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0002749
UniProt IDP48029
Primary gene name(s)SLC6A8
Synonym gene name(s)unknown
Protein nameSodium- and chloride-dependent creatine transporter 1
Protein functionRequired for the uptake of creatine in muscles and brain.
Subcellular locationMembrane;
Multi-pass membrane protein.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P48029
Gene Ontology
(Biological Process)
Complete annatation
creatine metabolic process [GO:0006600];
creatine transport [GO:0015881];
muscle contraction [GO:0006936];
transport [GO:0006810]
Gene Ontology
(Molecular Function)
Complete annatation
creatine:sodium symporter activity [GO:0005309];
creatine transmembrane transporter activity [GO:0005308];
neurotransmitter:sodium symporter activity [GO:0005328]
Gene Ontology
(Cellular Component)
Complete annatation
integral component of membrane [GO:0016021];
integral component of plasma membrane [GO:0005887];
plasma membrane [GO:0005886]
Protein-protein interaction112426
Phylogenetic treeP48029
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.1806710166858280.822327708305250.879055338284438
AZA vs. DISU-0.01621818947706410.9552078294068320.996649735504266
AZA vs. IL7-0.4108746942163580.0442363588962740.634897035201005
AZA vs. SAHA0.7918262021161540.00245774705579760.0385515911749147
DISU vs. CD3-0.2093022202800440.8050574779085330.866445553476597
DISU vs. IL7-0.403171095621850.1227604706694560.458754113867636
DISU vs. SAHA0.8102453720450130.009711844206293780.101573354637789
DMSO vs. AZA-0.06451962409202510.7773513720126221
DMSO vs. CD3-0.2603137867341310.7441378592026980.81516591864911
DMSO vs. DISU-0.05126477110348550.8534812481812930.983480838820316
DMSO vs. IL7-0.3375122234454480.07807508508863650.527085493824986
DMSO vs. SAHA0.8512704133947490.0006154109388679660.0125730352660641
HIV vs. Mock in Activation0.1593295963789470.916344672139350.999983755607037
HIV vs. Mock in Latency-0.2519199905470310.3771478543341860.999834320637052
IL7 vs. CD3-0.5847717318520730.4492348369765290.583244547023801
SAHA vs. CD30.5881903444309090.4331854033917740.546833977979061
SAHA vs. IL71.200272710422122.55980389074484e-060.000101545397120406
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.118815 0.741784
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB00148 Creatine approved, nutraceutical yes unknown

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found